These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5719518)

  • 21. The effect of fibrinolysis inhibitors on the ellagic acid activation of Hageman factor in the dog.
    Girolami A; Fioretti D; Cella G; Pedrazzoli G; Bernardi R
    Thromb Diath Haemorrh; 1971 Dec; 26(3):553-64. PubMed ID: 5316937
    [No Abstract]   [Full Text] [Related]  

  • 22. [Action of epsilon-aminocaproic acid as an anti-allergic agent and its effect on blood coagulation system].
    Zatikian LO
    Zh Eksp Klin Med; 1973; 13(3):16-9. PubMed ID: 4791710
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of aspirin and epsilon-aminocaproic acid on the duration of hemorrhage].
    Baranov AE; Kapustianova OI
    Probl Gematol Pereliv Krovi; 1972 Oct; 17(10):43-5. PubMed ID: 4668401
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the fibrinolytic activity of the plasma of thrombopenic patients and the effect of corticoids and epsilon-aminocaproic acid].
    Pileggi JE
    Sangre (Barc); 1967; 12(4):375-82. PubMed ID: 5614843
    [No Abstract]   [Full Text] [Related]  

  • 25. [Usefulness of EACA in conditions of fibrinolysis activation in obstetrics and gynecology].
    Trebicka-Kwiatkowska B; Radomański T; Ostasz T
    Wiad Lek; 1973 Feb; 26(4):297-303. PubMed ID: 4688816
    [No Abstract]   [Full Text] [Related]  

  • 26. [Acute effect of maternal smoking on fetal blood circulation].
    Dienes J; Takács T; Berkö P
    Orv Hetil; 1999 Nov; 140(45):2513-5. PubMed ID: 10586618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of epsilon-aminocapronic acid on fibrinolysis of euglobulins activated by endogenous activators of plasminogen].
    Chmielewski J
    Pol Tyg Lek; 1965 Jul; 20(27):990-1. PubMed ID: 5840160
    [No Abstract]   [Full Text] [Related]  

  • 28. [Epsylon-aminocaproic acid in the treatment of severe and dominating hyperfibrinolysis in a premature infant].
    Schmidt B; Pringsheim W; Künzer W
    Helv Paediatr Acta; 1980 Jul; 35(3):273-9. PubMed ID: 6773909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lillehei CW: Effect of epsilon aminocaproic acid upon blood loss following open-heart surgery: an analysis of 340 patients.
    Sterns LP
    Can J Surg; 1967 Jul; 10(3):304-7. PubMed ID: 6027393
    [No Abstract]   [Full Text] [Related]  

  • 30. [Permeability of the blood-aqueous barrier during inhibition of fibrinolysis in blood serum].
    Rudobielski R
    Klin Oczna; 1974 Mar; 44(3):239-42. PubMed ID: 4822124
    [No Abstract]   [Full Text] [Related]  

  • 31. A new concept in the control of acute gingival hemorrhage.
    Wells TJ
    J Oral Surg; 1976 May; 34(5):435-7. PubMed ID: 1083898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epsilon aminocaproic acid--a dangerous weapon.
    Ratnoff OD
    N Engl J Med; 1969 May; 280(20):1124-5. PubMed ID: 5813521
    [No Abstract]   [Full Text] [Related]  

  • 33. [Modification of hemorrhage after suprapubic prostatectomy with epsilon-aminocaproic acid].
    Ludvik W; Pecherstorfer M
    Wien Klin Wochenschr; 1967 May; 79(20):384-9. PubMed ID: 5589968
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical pharmacology of aminocaproic and tranexamic acids.
    Nilsson IM
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():41-7. PubMed ID: 7000846
    [No Abstract]   [Full Text] [Related]  

  • 35. Aminocaproic acid (epsilon aminocaproic acid) (Amicar).
    Haidet KK
    Neonatal Netw; 1995 Apr; 14(3):75-7. PubMed ID: 7603424
    [No Abstract]   [Full Text] [Related]  

  • 36. [Triggering of massive thrombus formation with epsilon-aminocaproic acid after previous activation of the coagulation system].
    Herschlein HJ; Steichele DF
    Thromb Diath Haemorrh; 1967 May; 17(3-4):568-77. PubMed ID: 5589304
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the effect of a new synthetic inhibitor of the fibrinolytic system].
    Fischer M; Pavlu C
    Arzneimittelforschung; 1966 May; 16(5):671-3. PubMed ID: 6014440
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antifibrinolytic and toxic properties of 5-aminocaproic acid under experimental conditions].
    Zaĭtseva RI
    Farmakol Toksikol; 1965; 28(2):196-9. PubMed ID: 5849201
    [No Abstract]   [Full Text] [Related]  

  • 39. [Can the blood of children who suffered interuterine death influence the homeostasis of blood coagulation and fibrinolysis in the mother with its fibrinolytic activity?].
    Poradovský K
    Zentralbl Gynakol; 1973 Mar; 95(11):379-83. PubMed ID: 4716653
    [No Abstract]   [Full Text] [Related]  

  • 40. [Influence of an inhibitor of fibrinolysis on the circulatory system of burned skin].
    Laurentaci G; Oliva V; Ferrarese S
    Boll Soc Ital Biol Sper; 1965 Apr; 41(8):413-4. PubMed ID: 5875562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.